OOIR: Observatory of International Research

Papers

(The TQCC of Annals of Allergy Asthma & Immunology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Neuromuscular blocking agent re-exposure in a retrospective cohort with neuromuscular blocking agent–associated anaphylaxis	234
Anaphylaxis to a particular brew of beer due to specific strains of Saccharomyces cerevisiae	91
The role of immunoglobulin A in oral tolerance and food allergy	75
Table of Contents	63
Stepping up our game with secondary immune deficiency	60
Is there value in coronavirus disease 2019 vaccine and vaccine excipient skin testing or split dosing?	57
Information for Readers	57
A new frontier in anaphylaxis management?	52
Table of Contents	50
Tastes great, less filling! Randomized trial comparing perceived palatability of dexamethasone preparations in children	47
Transitioning individuals with peanut allergy from US Food and Drug Administration-approved peanut oral immunotherapy to a dietary peanut product	47
Kounis syndrome	44
Immune-related cutaneous adverse events	44
Eosinophilic granulomatosis with polyangiitis presenting as aspirin–exacerbated respiratory disease	39
Challenge-confirmed diagnosis restores quality of life in cofactor-dependent wheat allergy	38
Use of omalizumab for management of idiopathic anaphylaxis	38
Is small airway dysfunction an abnormal phenomenon for patients with normal forced expiratory volume in 1 second and the ratio of forced expiratory volume in 1 second to forced vital capacity?	37
It takes a village to manage eosinophilic esophagitis	37
Quality of life in patients with hereditary angioedema in Canada	36
Immunoglobulin E deficiency . . . is that a thing?	35
Evaluation of anaphylaxis risk by skin testing with coronavirus disease 2019 messenger RNA vaccines on patients with anaphylaxis	35
Seafood-induced anaphylaxis in children presenting to Canadian emergency departments	35
Editorial Board	34
Editorial Board	34
Recent discoveries regarding the pathogenesis of chronic rhinosinusitis and their implications for future therapies	34

Predominance of Atopic Asthma in Patients with Severe or Difficult-to-Treat Asthma in the TENOR-II cohort	33
Cross-sectional study of urinary biomarkers of environmental tobacco and e-cigarette exposure and asthma morbidity	32
Negative penicillin skin testing induced anaphylaxis with concurrent beta blocker and angiotensin-converting enzyme inhibitor use	32
Evidence from mice that immunoglobulin E deficiency does not drive spontaneous malignancy	30
Table of Contents	29
Investigating air pollution as a contributor to health disparities during the coronavirus disease 2019 pandemic	28
Editorial Board	28
Book Review	28
Electronic medical record–based machine learning predicts the relapse of asthma exacerbation	28
Table of Contents	28
Information for Readers	27
Coconut allergy	27
Controversies in allergy, then and now	27
Treatment of a 4-year-old boy with mepolizumab for lymphocytic hypereosinophilic syndrome	26
Information for Readers	26
World Trade Center workers with asthma and post-traumatic stress disorder perceive airflow limitation more accurately	26
Family history of cancer predicts allergic rhinitis and asthma development	25
From the Pages of AllergyWatch	25
Table of Contents	25
Itching and Burning Man	24
A novel 2-step process for the management of inpatient beta-lactam allergy labels	24
Can patient-reported outcomes and inflammatory markers define endotype 2 in chronic rhinosinusitis without nasal polyps?	24
Optimizing clinical practice today while pondering an extraordinary immune system	24
Establishment of fluorescence multi-flow cytometric immunoassay for the simultaneous quantitative detection of six allergen-sIgE antibodies	23
Overcoming barriers to effective management of food-induced anaphylaxis in underserved populations through school-based interventions	23
WHY DO THOSE WHO NEED AN EPINEPHRINE AUTOINJECTOR NOT CARRY IT?: A CUSTOMER DISCOVERY APPROACH	23
Hereditary angioedema with normal C1-inhibitor	23
TRANSCRIPTION FACTORS IMPACT DIFFERENTIATION OF T-HELPER CELLS IN DEVELOPMENT OF ENDOMETRIOSIS WITH INFERTILITY	23
ASSOCIATION BETWEEN BASELINE CHARACTERISTICS AND ORAL CORTICOSTEROID REDUCTION IN PATIENTS WITH ORAL CORTICOSTEROID-DEPENDENT SEVERE ASTHMA	23
From the pages of AllergyWatch	23
IgG from individuals without atopy arising as mediators of a nonatopic profile in human peripheral CD4+ T cells	23
ALLERGIC SENSITIZATION TO INHALANT ALLERGENS IN THE UNITED STATES	23
Editorial Board	23
CD14 (C-159)T GENE POLYMORPHISM IN SARS-COV-2 PATIENTS IN CRIMEA	22
ALLERGIST ACCESS AS A POTENTIAL DRIVER OF SOCIOECONOMIC DISPARITIES IN FOOD ALLERGY	22
CLINICAL ASSESSMENT OF SAFETY, PHARMACOKINETICS, AND EFFICACY OF IMMUNE GLOBULIN INTRAVENOUS 10% IN PEDIATRIC PATIENTS	22
CHARACTERISTICS OF AN ADULT COHORT WITH SHELLFISH ALLERGY: COMPARISON BY RACE	22
METHODOLOGY OF THE CROSS-SECTIONAL STUDY FOR GLOBAL PREVALENCE AND SEVERITY OF FOOD ALLERGIES (ASSESS FA)	22
RESPIRATORY FUNCTIONS IN GIRLS WITH VARYING LEVELS OF PHYSICAL ACTIVITY	22
PREVALENCE AND INCIDENCE OF FOOD ALLERGIES IN THE US GENERAL POPULATION	21
TEZEPELUMAB REDUCES ALL KEY INFLAMMATORY BIOMARKER LEVELS IN PATIENTS WITH SEVERE ALLERGIC AND EOSINOPHILIC ASTHMA	20
WILDFIRE-ASSOCIATED INCREASE IN RELIEVER USE AMONG US ASTHMA PATIENTS: DATA FROM A DIGITAL HEALTH PLATFORM	20
RACIAL DISPARITIES IN ALLERGIC DISEASE IN AN URBAN PEDIATRIC POPULATION	20
RECENT REAL-WORLD BIOLOGIC UTILIZATION AMONG ADULTS WITH SEVERE ASTHMA: DATA FROM THE CHRONICLE STUDY	20
RELATIONSHIP BETWEEN D-DIMER LEVELS AND CLINICAL ACTIVITY OF SPONTANEOUS CHRONIC URTICARIA.	20
PREVALENCE OF ASTHMA ATTACKS AND EMERGENCY DEPARTMENT VISITS AMONG US WORKING ADULTS, 2020–2021	20
PERFORMANCE OF THE ASTHMA IMPAIRMENT AND RISK QUESTIONNAIRE (AIRQ) COMPARED TO EXISTING SYMPTOM CONTROL MEASURES	20
REASONS NOT TO TREAT HAE ATTACKS AND SATISFACTION FOR ON-DEMAND TREATMENT	19
HETEROGENEOUS CHARACTERISTICS OF SEVERE ASTHMA PATIENTS INITIATING BENRALIZUMAB IN A REAL-WORLD SETTING: THE ZEPHYR-4 STUDY	19
TIME TO SLEEP IMPROVEMENT IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA TREATED WITH OMALIZUMAB	19

TEZEPELUMAB EFFICACY IN PATIENTS WITH SEVERE ASTHMA BY BLOOD EOSINOPHIL COUNT AND PERENNIAL ALLERGY (DESTINATION)	18
BLACK CHILDREN WITH ECZEMA AND POSSIBLE FOOD ALLERGY ARE LESS LIKELY TO UNDERGO OBJECTIVE TESTING	18
HUMORAL IMMUNE RECONSTITUTION AFTER RITUXIMAB THERAPY IN THE PEDIATRIC POPULATION	18
FAILURE TO THRIVE IN INFANT WITH SEVERE ATOPIC DERMATITIS AND HYPEREOSINOPHILIA	18
A TWO STAGE ARTIFICIAL INTELLIGENCE (AI) DETECTION AND CLASSIFICATION MODEL FOR POLLEN GRAIN (PG) COUNTING.	18
FRACTIONAL EXHALED NITRIC OXIDE (FENO) IS A STABLE BIOMARKER IN PATIENTS WITH UNCONTROLLED ASTHMA	18
EFFECTIVENESS OF AN OPHTHALMIC SELECTIVE H1-RECEPTOR ANTAGONIST/MAST CELL STABILIZER AND NASAL GLUCOCORTICOSTEROID IN ALLERGIC CONJUNCTIVITIS	18
INCIDENCE AND PREDICTORS OF CUTANEOUS REACTIONS TO THE COVID-19 BOOSTER VACCINE	18
EXTENSIVE GASTROINTESTINAL DISEASE IN A PATIENT WITH AUTOSOMAL RECESSIVE CHRONIC GRANULOMATOUS DISEASE	17
A RARE CASE OF HELLS MUTATION CAUSING IMMUNODEFICIENCY, CENTROMERIC INSTABILITY, AND FACIAL ANOMALIES SYNDROME	17
Author Index	17
SYSTEMIC DERMATITIS AND EOSINOPHILIA FOLLOWING IVC PLACEMENT LIKELY DUE TO METAL HYPERSENSITIVITY	17
AMELIORATION OF SEVERE EXTRAGENITAL WARTS USING HPV VACCINATION: CASE REPORT AND SURVEY OF THE LITERATURE	17
DUPILUMAB TREATMENT FOR GLUCOCORTICOID DEPENDENT ADULT ONSET ATOPIC DERMATITIS AND HYPEREOSINOPHILIA SYNDROME	17
IMMUNE SYSTEM DYSREGULATION AND CLINICAL MANAGEMENT OF NEWBORN EXPOSED IN UTERO TO RAVULIZUMAB	16
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) PRESENTING AS EXTRAOCULAR MUSCLE ENLARGEMENT WITH EXOPHTHALMOS	16
A CASE OF REFRACTORY PRURITUS TREATED WITH PREGABALIN	16
CROHN'S DISEASE IN THE SETTING OF A VARIANT OF UNCERTAIN SIGNIFICANCE OF THE CYBB GENE	16
ASPIRIN EXACERBATED RESPIRATORY DISEASE WITH NEW ONSET LYMPHOCYTIC-VARIANT HYPEREOSINOPHILIC SYNDROME	16
SHOULD WE AVOID OVOMUCOID? A CASE OF BAKED EGG ANAPHYLAXIS	16
Research Abstract ToC	16
CARMINE RED DYE HYPERSENSITIVITY MASQUERADING AS SALMON ALLERGY	16
A NOVEL CASE OF FPIES AFTER PINE NUT FOOD CHALLENGE IN AN 18-YEAR-OLD FEMALE	16
UNIQUE PRESENTATION OF HYPEREOSINOPHILIC SYNDROME IN THE POSTPARTUM PERIOD WITH ATYPICAL FEATURES AND THERAPEUTIC CHALLENGES	16
EOSINOPHILIC CELLULITIS (WELLS SYNDROME) SUCCESSFULLY MANAGED WITH DUPILUMAB	16
SUCCESSFUL TREATMENT OF REFRACTORY ERYTHEMA ANNULARE CENTRIFUGUM WITH MEPOLIZUMAB	16
SEVERE REFRACTORY URTICARIA TREATED WITH RITUXIMAB: A CASE REPORT	15
SUCCESSFUL EGG REINTRODUCTION IN ADOLESCENT PATIENT WITH RECALCITRANT EGG ALLERGY	15
RITUXIMAB AS TREATMENT FOR SYMPTOMATIC LYMPHADENOPATHY IN COMMON VARIABLE IMMUNODEFIENCY	15
DOES TAKING LOCAL HONEY WORK? NOT ALWAYS: A CAUTIONARY TALE OF ANAPHYLAXIS TO HONEY	15
RECURRENT IGA VASCULITIS PRESENTING IN AN ADULT WITH WISKOTT-ALDRICH SYNDROME	15
NAVIGATING THE STORM: A TALE OF CHRONIC GRANULOMATOUS DISEASE, HLH-LIKE SYNDROME, AND UNDERLYING EBV INFECTION	15
CONTACT DERMATITIS OF THE HANDS CAUSED BY FLAXSEED IN ARTISTS PAINT	15
PNEUMOCYSTIS JIROVECII PRESENTING AS PULMONARY MASS IN PATIENT WITH COMMON VARIABLE IMMUNODEFICIENCY AND HEMATOLOGIC MALIGNANCY	14
LONG-TERM FOLLOW-UP OF A FAMILY WITH A HETEROZYGOUS VARIANT OF FOXN1	14
A CASE OF ATAXIA-TELANGIECTASIA WITH COMPOUND HETEROZYGOUS AT MUTATIONS DISCOVERED ON ABNORMAL NEWBORN SCREEN	14
RHIZOPUS INFECTION AND NEUTROPENIA LEADING TO DIAGNOSIS OF X-LINKED AGAMMAGLOBULINEMIA	14
HYPEREOSINOPHILIA DUE TO DISSEMINATED STRONGYLOIDIASIS IN A PEDIATRIC PATIENT	14
DE NOVO GELATIN HYPERSENSITIVITY FOLLOWING INTRAOPERATIVE GELFOAM EXPOSURE IN TWO PEDIATRIC LIVER TRANSPLANT RECIPIENTS	14
EVALUATING PATIENTS WITH RECURRENT FEVER AND ELEVATED IGD	14
COMPLEMENT FACTOR I DEFICIENCY PRESENTING WITHOUT IMMUNE DYSREGULATION	14
ABSENT SEROLOGIC MEMORY OF CHILDHOOD VACCINES FOLLOWED BY DEBILITATING CLINICAL RESPONSE TO MMRV VACCINE CHALLENGE	14
BEWARE OF THE TOXINS: CASTING A WIDE NET IN SUSPECTED FISH ALLERGY	14
A CASE OF AUTO-INFLAMMATORY DISEASE MIMICKING IMMUNODEFICIENCY	14
INDUCTION OF TOLERANCE TO PEANUT FOLLOWING DUPILUMAB THERAPY	14
A CASE OF SECONDARY HYPOGAMMAGLOBULINEMIA DUE TO PLASMA DONATION	14
CASE REPORT OF REAL-WORLD USE OF HUMAN-SLRA 10% THROUGH SUBCUTANEOUS INFUSION	14
IGE MEDIATED FLAXSEED ALLERGY IN NON-ATOPIC TODDLER POLYSENSITIZED TO TREE NUTS BUT TOLERATING OTHER SEEDS	14
A CASE OF ANAPHYLAXIS TO KETOROLAC IN A PEDIATRIC PATIENT	14
MORE THAN JUST CONTACT: INTRAOPERATIVE ANAPHYLAXIS DUE TO TOPICAL POLYMYXIN B / BACITRACIN	13
UNUSUAL PEDIATRIC REACTIONS TO MOSQUITO BITES	13
A CASE OF ERYTHEMA MULTIFORME FOLLOWING DUPILUMAB ADMINISTRATION IN A PEDIATRIC ATOPIC DERMATITIS PATIENT	13
SAFE ADMINISTRATION OF GCSF AFTER GRADED CHALLENGE IN PATIENT WITH DELAYED CUTANEOUS DRUG HYPERSENSITIVITY REACTION	13
CHARACTERIZING PEDIATRIC NATIVE AMERICAN PATIENTS WITH EOSINOPHILIC GASTROINTESTINAL DISEASE AT A SINGLE TERTIARY CARE CENTER	13
ASSESSING OUTCOMES OF A DEDICATED REFERRAL PATHWAY FOR EVALUATION OF PENICILLIN ALLERGY DURING PREGNANCY	13
VANCOMYCIN-INDUCED DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS) FOLLOWING ANTIBIOTIC-LOADED CEMENT SPACER PLACEMENT	13
C1 ESTERASE INHIBITOR THERAPY ENABLES HEALTHY PREGNANCY IN HEREDITARY ANGIOEDEMA PATIENT WITH RECURRENT LOSSES	13
DRUG ALLERGY OR MAST CELL ACTIVATION?	13
SERUM SICKNESS REACTION FOLLOWING RHO(D) IMMUNE GLOBULIN	13
ALLERGIC PROFILE IN PEDIATRIC KERATOCONUS ON A THIRD LEVEL HOSPITAL IN NORTHEASTERN MEXICO	13
ATYPICAL MANIFESTATIONS OF DRESS SYNDROME WITHOUT EOSINOPHILIA. CASE REPORT	13
A CASE OF RADIOCONTRAST DESENSITIZATION IN A HIGH-RISK CARDIAC PATIENT	13
HYBRID TELEMEDICINE FOR PATIENT CARE: INSIGHTS FROM A PATIENT SATISFACTION SURVEY	13
FACTITIOUS ANGIOEDEMA IN A 29-YEAR-OLD FEMALE WITH HISTORY OF TYPE 3 HEREDITARY ANGIOEDEMA	13
USE OF RITUXIMAB IN THE TREATMENT OF CHRONIC IDIOPATHIC URTICARIA: A CASE REPORT	13
TAPINAROF CREAM IMPROVED ITCH IN TWO PHASE 3 TRIALS OF MODERATE TO SEVERE ATOPIC DERMATITIS	13
REPETITIVE FOOD-INDEPENDENT EXERCISE-INDUCED ANAPHYLAXIS	13
REFRACTORY AQUAGENIC URTICARIA TREATED WITH OMALIZUMAB: A CASE REPORT AND SUMMARY OF THE LITERATURE	13
FIXED EXTRATHORACIC OBSTRUCTION MASQUERADING AS POORLY CONTROLLED ASTHMA	13
NEAR FATAL ANAPHYLAXIS IN A PATIENT WITH MULTIPLE DRUG INTOLERANCE SYNDROME (MDIS)	13
REFRACTORY SOLAR URTICARIA SUCCESSFULLY TREATED WITH OMALIZUMAB	13
ACTIGRAPHY AS AN OBJECTIVE MEASURE OF SLEEP DISRUPTION IN CHRONIC RHINOSINUSITIS	12
EVALUATION OF AN ALLERGY AND IMMUNOLOGY HANDBOOK TO IMPROVE MEDICAL EDUCATION FOR FELLOWS	12
Tiotropium for refractory cough in asthma via cough reflex sensitivity: A randomized, parallel, open-label trial	12
Immunologic biomarker changes in patients exposed to intravenous iodinated contrast material	12
A STUDY OF DUPILUMAB VERSUS PLACEBO IN PATIENTS WITH EOSINOPHILIC GASTRITIS WITH/WITHOUT EOSINOPHILIC DUODENITIS	12
HYPERSENSITIVITY TO PROTON PUMP INHIBITORS - A DIAGNOSTIC CHALLENGE	12
NOT ALL THAT MEETS THE HIVE: THE INITIAL PRESENTATION OF PEDIATRIC CHRONIC SPONTANEOUS URTICARIA	12
13.2 MG INTRANASAL EPINEPHRINE TREATMENT IN CONGESTION SHOWS INCREASED BIOAVAILABILITY WITHOUT PHARMACOKINETIC AND PHARMACODYNAMIC CORRELATION	12
Anxiety in adults with allergic rhinitis during the coronavirus disease 2019 pandemic: A Canadian perspective	12

TREATMENT OF HEREDITARY ANGIOEDEMA (HAE) WITH NORMAL C1-INH (HAE-NC1-INH) – A REAL-WORLD ACARE SURVEY	12
CLINICAL OUTCOMES AMONG INDIVIDUALS WITH ALPHA-1 ANTITRYPSIN DEFICIENCY ENROLLED IN MEDICARE ADVANTAGE	12
PRE-WORKOUT SMOOTHIES: BOON OR A BURDEN?	12
REAL-WORLD OUTCOMES IN PATIENTS WITH HAE RECEIVING LANADELUMAB LONG-TERM PROPHYLAXIS FOR 3 YEARS OR LONGER	12
SAFETY OF ANTI-SARS-COV-2 MONOCLONAL ANTIBODY THERAPIES: CLINICAL CHARACTERISTICS AND OUTCOMES OF ADVERSE DRUG REACTIONS	12
Immune-related cutaneous adverse events due to checkpoint inhibitors	12
UNPREDICTABLE AIRWAY COLLAPSE! A CASE OF ACQUIRED ANGIOEDEMA ASSOCIATED WITH B-CELL LYMPHOMA.	12
Hematopoietic stem cell transplant for the treatment of adenosine deaminase–deficient severe combined immune deficiency	11
M010 DIAGNOSTIC CHALLENGE IN EVALUATING THE RISK AND MANAGEMENT OF ALLERGIC REACTION(S) TO SARS-COV-2 VACCINES	11
P153 EFFICACY AND SAFETY OUTCOMES FOR PATIENTS WITH ALLERGIC COMORBIDITIES IN THE JADE PROGRAM	11
Skin as the target for allergy prevention and treatment	11
P190 ABROCITINIB EFFICACY AND SAFETY BY BODY WEIGHT: POOLED ANALYSIS OF 3 RANDOMIZED CLINICAL TRIALS	11
Editorial Board	11
Treatment goals in eosinophilic esophagitis: Looking beyond eosinophil count	11
New! American College of Allergy, Asthma and Immunology Annals fellow-in-training award program	11
Trends in the proportion of women speakers at North American Allergy and Immunology conferences, 2008 to 2020	11
M008 MANAGEMENT OF IOHEXOL-INDUCED ANAPHYLAXIS WITH ALTERNATIVE CONTRAST AGENTS	11
Skin testing as a biomarker in drug allergy	11
P196 PATIENT PERCEPTION OF TREATMENT WITH LONG-TERM DUPILUMAB MONOTHERAPY IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS	11
Drug desensitization in the coronavirus disease 2019 pandemic era	11
Comparing the nasal allergen challenge and environmental exposure unit models of allergic rhinitis	11
P180 A STICKY SITUATION: CASE SERIES OF SUCCESSFUL TREATMENT OF GLUE EAR OTITIS WITH DUPILUMAB	11
Lymphocyte transformation test for drug allergy detection	11
Effect of immune checkpoint inhibitors on asthma	11
M011 HYPERSENSITIVITY TO AMOXICILLIN-CLAVULANATE MANIFESTING AS ACUTE LOCALIZED EXANTHEMATOUS PUSTULOSIS	11
P075 PARTNERING WITH SCHOOL-BASED HEALTH CENTERS: A SUSTAINABLE MODEL OF COMMUNITY-BASED ASTHMA CARE	10
P109 IMPROVING IMPLEMENTATION OF EARLY PEANUT INTRODUCTION GUIDELINES AMONG PEDIATRIC HOUSE STAFF IN AN INNER-CITY HOSPITAL	10
P030 SIMILAR EFFICACY AND SAFETY BETWEEN ADOLESCENTS AND ADULTS RECEIVING HOUSE DUST MITE SUBLINGUAL IMMUNOTHERAPY TABLET	10
P070 EFFICACY OF BIOLOGIC THERAPIES IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA STRATIFIED BY BLOOD EOSINOPHIL COUNT	10
A022 ON-DEMAND ORAL TREATMENT WITH KVD900 FOR HAE ATTACKS ACHIEVES RAPID EXPOSURE AND IMPROVES PATIENT OUTCOMES	10
DESENSITIZATION TO EXTENSIVELY HYDROLYZED FORMULA IN INFANT WITH COW'S MILK PROTEIN ALLERGY	10
D031 LONGITUDINAL ANALYSIS OF SINGLE B CELLS, IGE ANTIBODIES, AND PLASMA IN A PEANUT ALLERGIC SUBJECT	10
P021 LUNG ACE2 AND TMPRSS2 GENE EXPRESSION VARIES WITH ALLERGEN EXPOSURES IN MURINE MODELS OF ASTHMA	10
P061 BENRALIZUMAB IS EFFECTIVE IN REDUCING ASTHMA EXACERBATIONS: RESULTS FROM THE ZEPHYR 2 STUDY	10
P093 IMMUNE GLOBULIN SUBCUTANEOUS (HUMAN) 20% SOLUTION ADMINISTRATION IN PRIMARY IMMUNODEFICIENCY DISEASES: A RETROSPECTIVE CHART REVIEW	10
M007 DRESS REACTION TO ANAKINRA IN A PATIENT WITH SEVERE SYSTEMIC JUVENILE ARTHRITIS (SJIA)	10
Table of Contents Oral Abstracts	10
PEANUT COMPONENT TESTING: NOT THE ONLY COMPONENT	10
A CASE OF MUCOUS MEMBRANE PEMPHIGOID PRESENTING TO ALLERGY CLINIC AS AN ADVERSE FOOD REACTION	10
P175 REDUCING ANTIBIOTIC EXPOSURE DURING PENICILLIN ALLERGY EVALUATIONS IN PREGNANCY	10
P091 BIOMARKERS OF INFLAMMATION AND IMMUNE REGULATION IN COVID-19 PATIENTS AND COVID 19 VACCINATED INDIVIDUALS	10
A082 ONE VS TWO-DAY ASPIRIN DESENSITIZATION IN ASPIRIN EXACERBATED RESPIRATORY DISEASE: A QUALITY IMPROVEMENT PROJECT	10
P049 LIGELIZUMAB ACHIEVES FREEDOM FROM DISEASE ACTIVITY IN CHRONIC SPONTANEOUS URTICARIA REGARDLESS OF PREVIOUS H1-ANTIHISTAMINE DOSE	10
CLINICAL ASSESSMENT OF PHARMACOKINETICS AND SAFETY OF NOVEL GLYCINE STABILIZED 10% IVIG IN PIDD PATIENTS	10
POST THYMECTOMY: AN EXAMPLE OF IMMUNE DYSREGULATION?	10
LATE-ONSET COMBINED IMMUNE DEFICIENCY IN A PATIENT WITH ADENOSINE DEAMINASE GENE MUTATION	10
P171 IMPLEMENTATION OF A PENICILLIN SKIN TESTING SERVICE IN INPATIENTS WITH HEMATOLOGIC MALIGNANCIES	10
VENOM IMMUNOTHERAPY: SELECTIVE DESENSITIZATION	9
APPROACHING THE STIFF UPPER LIP: A CASE OF PSEUDOANGIOEDEMA DIAGNOSED AS OROFACIAL GRANULOMATOSIS	9
MORE THAN JUST A “RUNNY NOSE”: A COMBINATION OF VASOMOTOR RHINITIS AND CEREBROSPINAL FLUID LEAK	9
Table of Contents Research Abstracts	9
PATIENTS’ PERSPECTIVE ON THE BURDEN OF HYPEREOSINOPHILIC SYNDROME	9
PROGESTOGEN HYPERSENSITIVITY – A CASE SERIES	9
ANTROCHOANAL POLYP: AN UNCOMMON CAUSE OF CHRONIC NASAL CONGESTION IN PEDIATRIC PATIENTS	9
SEVERE INFLAMMATORY RESPONSE SYNDROME AFTER TMP-SMX IN A HEALTHY PATIENT	9
BIPHASIC ALLERGY TO ACETAMINOPHEN: AN ADDITIONAL APPEARANCE IN THE POST-DELIVERY POPULATION	9
EVALUATION AND MANAGEMENT OF DELAYED HYPERSENSITIVITY REACTION TO INSULIN IN	9
PREVALENCE AND CHARACTERISTICS OF EOSINOPHILIC ESOPHAGITIS IN 2019	9
SEVERE PRURITUS AS A PRESENTING SYMPTOM OF HODGKIN'S LYMPHOMA	9
A NUTTY CASE: RARE PRESENTATION OF ALLERGIC VAGINITIS	9
RECURRENT LUNG INFECTIONS IN A HETEROZYGOUS CARRIER OF NOVEL NSMCE3 MUTATION.	9
OMALIZUMAB: A POTENTIAL LONG-TERM THERAPEUTIC ALTERNATIVE FOR REFRACTORY DELAYED PRESSURE URTICARIA?	9
A NOVEL PROTEIN KINASE, DNA-ACTIVATED, CATALYTIC SUBUNIT VARIANT IDENTIFIED IN T-B-NK+ SEVERE COMBINED IMMUNODEFICIENCY	9
AN UNUSUAL CASE OF CHRONIC COUGH IN A PEDIATRIC PATIENT	9
PERSISTENTLY ELEVATED BASELINE TRYPTASE - A CASE OF HEREDITARY ALPHA TRYPTASEMIA	9
SYSTEMIC MASTOCYTOSIS PRESENTING WITH KOUNIS SYNDROME AND REFRACTORY SHOCK	9
RELIABILITY OF BANANA-SPECIFIC IGE TESTING PRIOR TO ORAL FOOD CHALLENGE	8
PARENT-REPORTED OUTCOMES DESIGN IN A DIGITAL EARLY ALLERGEN FEEDING STUDY WITH ECZEMATOUS AND NON-ECZEMATOUS INFANTS	8
PATIENT AND CLINICIAN PREFERENCES WITH BIOLOGIC TREATMENTS FOR SEVERE ASTHMA: A DISCRETE CHOICE EXPERIMENT	8
EFFICACY OF PINE NUT-SPECIFIC IGE TESTING PRIOR TO ORAL FOOD CHALLENGE	8
IMPACT OF HEREDITARY ANGIOEDEMA (HAE) ATTACKS ON QUALITY OF LIFE AND ACTIVITIES OF DAILY LIVING	8
TIME TO CLINICALLY MEANINGFUL RESPONSE TO OMALIZUMAB IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA	8
A UNIQUE CASE OF ALLERGIC URTICARIA AND ANGIOEDEMA SECONDARY TO ICODEXTRIN	8
SUSTAINED IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE WITH CONTINUED LANADELUMAB TREATMENT IN HEREDITARY ANGIOEDEMA	8
USING AREA DEPRIVATION INDEX TO ASSESS RACIAL DISPARITIES IN ASTHMA AMONG CHILDREN WITH FOOD ALLERGY	8
THE LEARN EARLY PROJECT: LEARNING EDUCATORS ANAPHYLAXIS RESPONSE NEEDS	8
CHARACTERISTICS OF PEDIATRIC PATIENTS WITH IGE-MEDIATED ALLERGY TO GREEN PEA	8
RESULTS OF A PHASE 4 STUDY OF IMMUNOGLOBULIN [HUMAN] SUBCUTANEOUS FOR PATIENTS REQUIRING IMMUNOGLOBULIN	8
THE IMPACT OF COVID-19 PANDEMIC ISOLATION MEASURES ON PEDIATRIC ASTHMA ADMISSIONS	8
DEVELOPMENT OF THE PATIENT-IMPORTANT OUTCOMES NATIONAL DATA REPOSITORY (PIONEER) FOR HEREDITARY ANGIOEDEMA (HAE)	8
INCREASING THE PERCENTAGE OF PATIENTS THAT RECEIVE THE INFLUENZA VACCINE IN ALLERGY SHOT CLINICS	8
SYNDROME OF THYROID AUTOIMMUNITY AND IDIOPATHIC CHRONIC URTICARIA AND ANGIOEDEMA	8
A CASE OF DIFFICULT TO DIAGNOSE C1INH NORMAL HAE	8
REDUCTIONS IN EXACERBATIONS OF SEVERE ASTHMA PATIENTS TREATED WITH BENRALIZUMAB – ZEPHYR 3	8
LIABILITY: A MISUNDERSTOOD BARRIER TO STOCK ALBUTEROL IMPLEMENTATION IN ILLINOIS SCHOOLS	8
IMPACT OF ACCESS TO ALLERGEN-FREE FOOD OPTIONS THROUGH WIC ON FOOD ALLERGY-RELATED QUALITY OF LIFE	8
AN EMR INTERVENTION TO IMPROVE EARLY INTRODUCTION OF PEANUTS IN INFANTS AT COMMUNITY-BASED HEALTH CLINICS	8
THE IMPORTANCE OF B CELLS IN OVERCOMING COVID-19 INFECTION IN COMMON VARIABLE IMMUNODEFICIENCY PATIENTS.	8
LONG-TERM SAFETY AND EFFICACY OF DUPILUMAB IN CHILDREN WITH ASTHMA: LIBERTY ASTHMA EXCURSION	8
ENVIRONMENTAL FACTORS INFLUENCING SYMPTOMS AND USE OF RELIEF MEDICATIONS IN SUBJECTS WITH SEASONAL ALLERGIC RHINOCONJUNCTIVITIS	8
RARE MUTATION IN AIRE GENE IDENTIFIED IN PATIENT WITH VERY EARLY ONSET IBD	8
SEVERE ATOPIC DERMATITIS IMPROVED WITH OMALIZUMAB TREATMENT OF CHOLINERGIC URTICARIA	8
REAL-WORLD BENRALIZUMAB EFFECTIVENESS AMONG ASTHMA PATIENTS WITH COMORBID NASAL POLYPS: RESULTS FROM THE ZEPHYR2 STUDY	8
DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGIC PATIENTS ACROSS SEVERITY AND ALLERGENS: A NATIONWIDE US SURVEY	8
PHARMACOKINETICS AND PHARMACODYNAMICS OF ARS-1 AND MANUAL INTRAMUSCULAR INJECTION IN SUBJECTS WITH/WITHOUT ALLERGIC RHINITIS	8